Name: CNTA Balance Sheet - Centessa Pharmaceuticals Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

CNTA - Centessa Pharmaceuticals PLC

USD | NASDAQ | Healthcare

CNTA Balance Sheet - Centessa Pharmaceuticals Assets & Debt | Ledgeburg

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020
Cash And Short Term Investments
Cash And Equivalents	61.3	383.2	128.0	393.6	595.1	7.2
Restricted Cash	-	-	-	-	-	-
Short Term Investments	233.3	99.0	128.5	0.0	-	-
Cash And Short Term Investments	294.6	482.2	256.5	393.6	595.1	7.2
Receivables
Accounts Receivable	-	-	-	-	-	-
Current Assets
Inventory	-	-	-	-	-	-
Prepaid Expenses	19.4	10.5	20.7	19.9	18.3	1.3
Other Current Assets
Non-Current Assets
Property, Plant & Equipment Gross	1.9	1.5	1.5	1.3	0.2	-
Accumulated Depreciation	1.1	0.8	0.5	0.2	0.0	0.0
Current Liabilities
Accounts Payable	7.6	7.1	11.8	13.8	8.1	1.0
Short Term Debt	-	-	-	-	-	5.6
Deferred Revenue Current
Non-Current Liabilities
Long Term Debt	110.1	108.9	75.7	69.8	75.7	0.0
Operating Lease Liabilities Non-Current	7.6	8.3	8.9	0.0	-	-
Common Equity
Common Stock	0.4	0.4	0.3	0.3	0.3	-
Additional Paid In Capital	1,710.0	1,385.7	987.4	939.3	876.3	-
Retained Earnings
Supplementary Data
Total Debt	110.1	108.9	75.7	69.8	75.7	5.6
Net debt	(184.5)	(373.2)	(180.8)	(323.8)	(519.4)	(1.6)
Working Capital

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20
Cash And Short Term Investments
Cash And Equivalents	62.4	61.3	50.8	44.2	105.2	383.2	395.0	127.4	118.2	128.0	171.5	145.2	260.0	393.6	444.8

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Current Assets
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses	15.7	19.4	12.3	8.9	13.6	10.5	15.9	18.8	18.0	20.7	22.7	19.7	17.8	19.9	12.2	16.4	16.1	-
Other Current Assets	2.1	1.8	2.8	1.6	1.6	1.5	2.7	2.0	1.8	1.6	2.9	3.9	3.1	3.3	1.3	1.1	1.1
Assets Held For Sale	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Assets	348.7	367.9	307.7	300.4	347.7	536.4	568.4	355.5	284.5	315.1	332.5	350.4	384.3	437.7	477.0	519.5

Non-Current Assets
Property, Plant & Equipment Gross	1.9	1.9	1.9	1.7	1.5	1.5	1.5	1.5	1.5	1.5	1.5	1.4	1.4	1.3	0.7	1.0	0.4	-	-	-	-	-
Accumulated Depreciation	1.2	1.1	1.0	0.9	0.9	0.8	0.7	0.6	0.5	0.5	0.4	0.3	0.2	0.2	0.1	0.1	0.1
Property,Plant & Equipment Net	0.7	0.8	0.9	0.7	0.7	0.7	0.8	0.9	1.0	1.0	1.1	1.1	1.2	1.2	0.6	0.9	0.4
Long Term Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Equity Method Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Goodwill	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Intangible Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Right Of Use Assets	9.8	10.0	10.3	10.5	10.8	11.0	11.2	11.5	11.7	11.9	12.1	12.3	12.3	0.0	-	-
Deferred Tax Assets	24.2	24.8	25.0	25.4	26.4	26.6	27.1	28.6	29.2	29.6	29.6	26.8	-	3.5	-	-	-
Other Non-Current Assets	1.3	1.4	1.6	1.7	1.9	2.0	2.2	2.4	1.9	2.6	2.1	2.3	6.0	1.9	-	-	-
Total Non-Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	641.8	687.5	448.3	492.1	527.8	576.8	609.7	398.8	328.2	360.2	377.4	392.9	403.9	444.3	479.4	521.1	582.2

Current Liabilities
Accounts Payable	10.7	7.6	8.7	5.7	5.1	7.1	7.4	5.3	7.5	11.8	10.8	11.1	14.4	13.8	10.9	8.2	6.7	-	18.5	7.3	-	1.0
Short Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Current	0.7	0.7	0.7	0.7	0.6	0.6	0.6	0.6	0.5	0.5	0.5	0.5	0.4	0.0	-	-
Accrued Expenses	25.9	35.4	20.4	24.0	19.1	50.9	19.0	21.4	19.9	27.6	24.1	22.8	15.3	24.5	27.3	25.3	20.5	-
Other Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Liabilities	36.6	42.9	29.1	29.7	24.2	58.0	26.4	26.8	27.4	39.4	35.0	33.9	29.7	38.3	38.2

Non-Current Liabilities
Long Term Debt	110.4	110.1	109.8	109.5	109.3	108.9	75.7	76.5	76.8	75.7	74.0	73.3	71.6	69.8	68.2	67.4	74.8	-	-	-	-	-
Operating Lease Liabilities Non-Current	7.4	7.6	7.8	7.9	8.1	8.3	8.4	8.6	8.7	8.9	9.0	9.1	9.3	0.0	-	-
Deferred Revenue Non-Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Tax Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pension Obligations	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Liabilities	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-	-	-	-	0.0	0.0
Total Non-Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	154.4	160.6	146.7	147.2	141.6	175.3	110.6	111.9	113.0	124.0	118.0	116.3	110.6	108.1	106.4	101.0

Common Equity
Common Stock	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	-	0.3	0.3	-	-
Additional Paid In Capital	1,751.0	1,710.0	1,418.7	1,408.1	1,398.6	1,385.7	1,374.1	1,119.9	1,004.3	987.4	974.4	952.9	946.2	939.3	933.0	925.7
Retained Earnings	(1,265.5)	(1,186.2)	(1,120.1)	(1,065.2)	(1,014.8)	(988.7)	(877.4)	(834.8)	(791.0)	(752.9)	(716.1)	(677.5)	(652.6)	(601.9)	(558.7)	(504.8)	(440.2)
Accumulated Other Comprehensive Income	1.4	2.7	2.6	1.6	2.1	4.2	2.1	1.6	1.6	1.5	0.8	0.9	(0.6)	(1.5)	(1.7)	(1.1)
Treasury Stock	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Stockholders Equity	487.3	526.9	301.6	344.9	386.2	401.5	499.1	287.0	215.2	236.2	259.4	276.6	293.3	336.2	372.9	420.0	480.2
Total Equity	487.3	526.9	301.6	344.9	386.2	401.5	499.1	287.0	215.2	236.2	259.4	276.6	293.3	336.2	372.9	420.0	480.2	(4.7)